Scherpbier, H.J.

children patient score growth infection haart therapy baseline weight immunodeficiency change immunodeficiency virus infection virus study count indinavir height month pretreated patients 96 weeks antiretroviral therapy range pediatrics increase treatment virologic zidovudine effect inhibitor antiretroviral t-cell responder adherence response height z score result group adult 6 months weight z score pretreated bmi z score disease haart initiation nonresponder center value protease plasma virologic responders pediatr week 48 immunodeficiency virus initiation reference difference hospital erasmus rotterdam 48 weeks combination virologic response trial hiv infection z score change bmi z scores 2.70 z scores immunologic j pediatr weight gain lamivudine medication level immunodeficiency syndrome plasma hiv reference value month 6 limit protease inhibitor stage